LIVZON PHARMA (01513) spent 8.7832 million yuan on September 24 to repurchase 250,000 shares of A shares.
Lizhu Pharmaceutical (01513) announced that the company invested 8.7832 million yuan on September 24, 2024...
LIVZON PHARMA (01513) announced that the company spent 8.7832 million yuan to repurchase 250,000 A shares on September 24, 2024. The repurchase price was between 34.95 yuan and 35.76 yuan per share.
Related Articles
US Stock Market Move | Futu Holdings Ltd. Sponsored ADR Class A (FUTU.US) rose more than 3% with Goldman Sachs Group, Inc. upgrading its rating to "buy."
IMMUNOTECH-B (06978) plans to issue new convertible bonds worth 270 million yuan and promissory notes worth 30 million yuan.
One of the actual controllers of Hangzhou Changchuan Technology (300604.SZ), Changchuan Investment, plans to reduce its shareholding by no more than 1.1128%.
US Stock Market Move | Futu Holdings Ltd. Sponsored ADR Class A (FUTU.US) rose more than 3% with Goldman Sachs Group, Inc. upgrading its rating to "buy."
IMMUNOTECH-B (06978) plans to issue new convertible bonds worth 270 million yuan and promissory notes worth 30 million yuan.
One of the actual controllers of Hangzhou Changchuan Technology (300604.SZ), Changchuan Investment, plans to reduce its shareholding by no more than 1.1128%.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
